Biosero

San Diego, CA, USA

Biosero develops device-agnostic automation software, Green Button Go™ Automation Scheduling Software, for life science, pharmaceutical, and industrial manufacturing. The software enables complex, data-driven decisions and integrates hardware solutions from various OEMs to accelerate operations and increase productivity in laboratories, supporting drug discovery and development.

Shareable draft

Check out Biosero on @MedStartr Today Biosero develops device-agnostic automation software, Green Button Go™ Automation Scheduling Software, for life science, pharmaceutical, and industrial manufacturing. The software enables complex, data-driven decisions and integrates hardware solutions from various OEMs to accelerate operations and increase productivity in laboratories, supporting drug discovery and development. #DrugDevelopment #HepatitisC #PainReduction #Diagnostics #MultiOmics #TissueEngineering #CellLineDevelopment #CellGeneTherapy #PersonalizedMedicine #PrecisionMedicine #ProteinCharacterization #COVID19 #MentalBehavioralHealth #CancerOncology #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/omXmOEDmbhc

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Biosero

1 engagement

How We Help

Problem Statement

Biosero addresses the challenge of integrating and orchestrating diverse laboratory instruments and systems to eliminate bottlenecks in scientific discovery, thereby improving data integrity, reproducibility, and overall lab productivity for research and development.

Core Technology

automation software, Green Button Go™ Automation Scheduling Software

Key Differentiators

Hardware-agnostic Green Button Go software allowing flexible integration of diverse instruments; focus on end-to-end workflow orchestration; new assistive AI capabilities to accelerate research; over 20 years of experience as a trusted partner to top pharmaceutical and diagnostics companies globally.

Clinical Focus

Life science research and development, including drug development, diagnostics, multi-omics, tissue engineering, cell line development, cell & gene therapy, personalized medicine, precision medicine, and protein characterization. Specific support for areas like Hepatitis C, pain reduction, cancer, and COVID-19 diagnostics/research.

Target Customers

Life science research and development organizations, top pharmaceutical companies, and diagnostics companies globally.

Product Stage

Mature

Company Info

Business Model: B2B SaaS
Founded: 2003
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.biosero.com

Disease Areas

Drug Development Hepatitis C Pain Reduction Diagnostics Multi-Omics Tissue Engineering Cell Line Development Cell & Gene Therapy Personalized Medicine Precision Medicine Protein Characterization COVID-19 Mental Health Cancer & Oncology

Technologies

Software SuiteDevice-Agnostic IntegrationWorkflow OrchestrationAssistive AINLPLaboratory Automation

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Biosero?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.